General Information of the Compound
| Compound ID |
CP0039686
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
1-methyl-4,4-diphenyl-4,5-dihydro-1H-imidazol-2-amine
Show/Hide
|
||||||||||||||||||
| Synonyms |
1-methyl-4,4-diphenyl-4,5-dihydro-1H-imidazol-2-amine
2-Imino-3-methyl-5,5-diphenyl-imidazolidin-4-one
2-Imino-3-methyl-5,5-diphenylimidazolidin-4-one
2-amino-3-methyl-5,5-diphenyl-3,5-dihydro-imidazol-4-one
26975-80-4
5,5-Diphenyl-2-iminohydantoin
BDBM50300229
CHEMBL291784
SCHEMBL4237550
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C16H15N3O
|
||||||||||||||||||
| Molecular Weight |
265.316
|
||||||||||||||||||
| Canonical SMILES |
CN1C(N)=NC(C1=O)(c1ccccc1)c1ccccc1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C16H15N3O/c1-19-14(20)16(18-15(19)17,12-8-4-2-5-9-12)13-10-6-3-7-11-13/h2-11H,1H3,(H2,17,18)
Show/Hide
|
||||||||||||||||||
| InChIKey |
RNWLAFWLSSMCLN-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01151, Amyloid-beta precursor protein
Protein ID: PT01020, Beta-secretase 1
Clinical Information about the Compound
Drug 1 ( 5,5-Diphenyl-2-iminohydantoin )
| Drug Name | 5,5-Diphenyl-2-iminohydantoin | ||
|---|---|---|---|